Glaukos COO shares product updates, 2021 pipeline
January 31st 2021Glaukos Corporation's COO Chris Calcaterra gives an update on the company's latest 24-month phase 2b data for its iDose TR sustained-release travoprost implant, next steps for securing FDA approval, and his outlook for 2021.
Read More
Clear lens extraction surgery: Pinpointing the optimal time in glaucoma patients
January 24th 2021The traditional treatment for primary angle-closure (PAC) and PAC glaucoma (PACG) is laser peripheral iridotomy (LPI) to facilitate aqueous outflow followed by medical treatment with drops to decrease the intraocular pressure (IOP).
Read More
Evaluating long-term safety of micro-bypass implant with phaco in PXG
December 12th 2020Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.
Read More
Single administration of intracameral bimatoprost implant: IOP lowering, safety
December 2nd 2020Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.
Read More
COVID-19 safety challenges accelerating welcome changes
September 17th 2020One ophthalmic practice's staff has found that, despite the challenges faced by all healthcare professionals amid the coronavirus pandemic, a few proverbial “silver lining” practice adaptations will endure long after the crisis is over.
Read More